Celularity (CELUW) Competitors $0.05 +0.00 (+4.20%) As of 11:37 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock CELUW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CINGWShould you be buying Celularity stock or one of its competitors? The main competitors of Celularity include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. Celularity vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Cingulate Celularity (NASDAQ:CELUW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation. Does the media refer more to CELUW or ATNFW? In the previous week, Celularity and Celularity both had 1 articles in the media. Celularity's average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that Celularity is being referred to more favorably in the media. Company Overall Sentiment Celularity Very Positive 180 Life Sciences Very Positive Is CELUW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets CelularityN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the MarketBeat Community believe in CELUW or ATNFW? Celularity and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCelularityN/AN/A180 Life SciencesN/AN/A Which has stronger earnings and valuation, CELUW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCelularity$54.22MN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryCelularity beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Get Celularity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELUW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELUW vs. The Competition Export to ExcelMetricCelularityBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$127.75M$5.60B$8.61BDividend YieldN/A3.74%5.28%4.18%P/E RatioN/A3.3027.2219.97Price / SalesN/A4,209.35408.95152.58Price / CashN/A13.1938.2534.64Price / BookN/A37.927.114.68Net IncomeN/A-$91.56M$3.24B$248.05M7 Day PerformanceN/A1.93%2.47%2.40%1 Month PerformanceN/A7.75%8.66%6.14%1 Year PerformanceN/A175.78%31.22%13.62% Celularity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELUWCelularityN/A$0.05+4.2%N/A+122.2%$0.00$54.22M0.00220Positive NewsGap DownATNFW180 Life SciencesN/A$0.01-3.1%N/A-42.3%$0.00N/A0.007LBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01+4.5%N/AN/A$0.00N/A0.002Gap UpHigh Trading VolumeAIMDWAinosN/A$0.16+6.9%N/A+67.4%$0.00$106.21K0.0040ALVOWAlvotechN/A$2.41-3.6%N/A-35.8%$0.00$585.60M0.004ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02+27.7%N/AN/A$0.00N/A0.0015Gap UpBFRIWBiofronteraN/A$0.14+49.5%N/A+75.2%$0.00$38.00M0.0070BTMDWbioteN/A$0.03+26.7%N/A-93.9%$0.00$199.38M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.09-12.6%N/A-74.7%$0.00N/A0.008Short Interest ↑CINGWCingulateN/A$0.05-2.2%N/A+332.0%$0.00N/A0.0020Positive News Related Companies and Tools Related Companies ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ACABW Alternatives BFRIW Alternatives BTMDW Alternatives BCTXW Alternatives CINGW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELUW) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celularity Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celularity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
